What’s new at the Rosalind & Morris Goodman Cancer Institute?

Four research teams from the Rosalind & Morris Goodman Cancer Institute (GCI) are among the recipients of the 2026 Cancer Research Society (CRS) Operating Grants.

In a new Perspective in Cell Metabolism, Rosalind & Morris Goodman Cancer Institute (GCI) researchers Lawrence Kazak, PhD, and co-authors Mohammed Faiz Hussain, Mina Ersin, and Maria Delgado-Martin argue that heat production in adipose tissue is a team effort between parallel pathways.

Simon Roy, M.D. M.H.S, and Hannah Garner, PhD, two researchers at the Rosalind & Morris Goodman Cancer Institute (GCI), were respectively awarded clinical-research scholar and research scholar awards from the Fonds de Recherche du Québec (FRQ) – Santé.

GCI researcher Lawrence Kazak awarded the 2026 Natural Sciences and Engineering Research Council of Canada (NSERC) Arthur B. McDonald Fellowship.

For Breast Cancer Awareness Month, the GCI is highlighting a new study on early breast cancer by researcher William Muller and his team. The study reveals a new therapeutic target that could help clinicians better treat and prevent invasive disease.

McGill University, the Rosalind and Morris Goodman Cancer Institute, the Research Institute of the McGill University Health Centre, the Jewish General Hospital and Lady Davis Institute, as well as our partners across the Marathon of Hope Québec (MOHQ) Consortium, are proud to be part of the second phase of the Marathon of Hope Cancer Centres Network (MOHCCN) announced on September 24, 2026, by the Terry Fox Research Institute and the Government of Canada.

Simon Roy, M.D. M.H.S, Principal Investigator at the Rosalind & Morris Goodman Cancer Institute (GCI) and Assistant Professor in the Department of Pathology, has been awarded a competitive grant from the V Foundation for Cancer Research, valued at $800,000 USD, to investigate why immunotherapy so often fails in patients with acral melanoma, a rare and aggressive form of skin cancer.

Professors Arnim Pause, PhD, and Lawrence Kazak, PhD, of the Rosalind & Morris Goodman Cancer Institute (GCI) were both awarded Canadian Institutes of Health Research (CIHR) Project Grants this Fall.

With the start of the 2026-2027 academic year, the Rosalind & Morris Goodman Cancer Institute (GCI) highlights the trainees who lead the Goodman Cancer Student Society (GCSS) and create a stronger and more inclusive student community. This year, Paulina Varela and Deepashika Senaratne are the newly elected co-presidents, and Ariadna Pollato holds the role of vice-president finance.